F
$ Value
$45K
Shares
11,400
Price
$4
Filed
Feb 10
Insider
Name
Hallett David
Title
Chief Scientific Officer
CIK
0002006495
Roles
Officer
Transaction Details
Transaction Date
2026-02-06
Code
F
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
1,109,059
Footnotes
This RSU vests as to one one-sixteenth (1/16th) of the units subject the RSU on May 15, 2026 and every three months thereafter. | This RSU vested immediately upon the grant date. | Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units.
Filing Info
Hallett David's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-17 | RXRX | F | $42K |
| 2026-02-06 | RXRX | A | $0 |
| 2026-02-06 | RXRX | A | $0 |
| 2026-02-06 | RXRX | F | $45K |
Other Insiders at RXRX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Taylor Ben R
Chief Financial Officer
|
— | $68K | 2026-04-06 |
| Li Dean Y | — | — | 2026-04-01 |
| Dar Zavain | — | — | 2026-04-01 |
| Borgeson Blake | — | $1.6M | 2026-04-07 |
| Gibson Christopher | — | $557K | 2026-04-07 |
|
Hallett David
Chief Scientific Officer
|
— | — | 2026-02-17 |
|
Khan Najat
CEO and President
|
— | $95K | 2026-03-09 |